Cargando…
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
Breast cancer has the highest incidence and mortality in women worldwide. There are 70% of breast cancers considered as estrogen receptor α (ERα) positive. Therefore, the ERα-targeted therapy has become one of the most effective solution for patients with breast cancer. Whereas a better understandin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997968/ https://www.ncbi.nlm.nih.gov/pubmed/33771975 http://dx.doi.org/10.1038/s41419-021-03607-w |
_version_ | 1783670444401885184 |
---|---|
author | Xia, Xiaohong Huang, Chuyi Liao, Yuning Liu, Yuan He, Jinchan Shao, Zhenlong Hu, Tumei Yu, Cuifu Jiang, Lili Liu, Jinbao Huang, Hongbiao |
author_facet | Xia, Xiaohong Huang, Chuyi Liao, Yuning Liu, Yuan He, Jinchan Shao, Zhenlong Hu, Tumei Yu, Cuifu Jiang, Lili Liu, Jinbao Huang, Hongbiao |
author_sort | Xia, Xiaohong |
collection | PubMed |
description | Breast cancer has the highest incidence and mortality in women worldwide. There are 70% of breast cancers considered as estrogen receptor α (ERα) positive. Therefore, the ERα-targeted therapy has become one of the most effective solution for patients with breast cancer. Whereas a better understanding of ERα regulation is critical to shape evolutional treatments for breast cancer. By exploring the regulatory mechanisms of ERα at levels of post-translational modifications, we identified the deubiquitinase USP15 as a novel protector for preventing ERα degradation and a critical driver for breast cancer progression. Specifically, we demonstrated that USP15 promoted the proliferation of ERα(+), but not ERα(-) breast cancer, in vivo and in vitro. Meanwhile, USP15 knockdown notably enhanced the antitumor activities of tamoxifen on breast cancer cells. Importantly, USP15 knockdown induced the downregulation of ERα protein via promoting its K48-linked ubiquitination, which is required for proliferative inhibition of breast cancer cells. These findings not only provide a novel treatment for overcoming resistance to endocrine therapy, but also represent a therapeutic strategy on ERα degradation by targeting USP15-ERα axis. |
format | Online Article Text |
id | pubmed-7997968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-79979682021-04-16 The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression Xia, Xiaohong Huang, Chuyi Liao, Yuning Liu, Yuan He, Jinchan Shao, Zhenlong Hu, Tumei Yu, Cuifu Jiang, Lili Liu, Jinbao Huang, Hongbiao Cell Death Dis Article Breast cancer has the highest incidence and mortality in women worldwide. There are 70% of breast cancers considered as estrogen receptor α (ERα) positive. Therefore, the ERα-targeted therapy has become one of the most effective solution for patients with breast cancer. Whereas a better understanding of ERα regulation is critical to shape evolutional treatments for breast cancer. By exploring the regulatory mechanisms of ERα at levels of post-translational modifications, we identified the deubiquitinase USP15 as a novel protector for preventing ERα degradation and a critical driver for breast cancer progression. Specifically, we demonstrated that USP15 promoted the proliferation of ERα(+), but not ERα(-) breast cancer, in vivo and in vitro. Meanwhile, USP15 knockdown notably enhanced the antitumor activities of tamoxifen on breast cancer cells. Importantly, USP15 knockdown induced the downregulation of ERα protein via promoting its K48-linked ubiquitination, which is required for proliferative inhibition of breast cancer cells. These findings not only provide a novel treatment for overcoming resistance to endocrine therapy, but also represent a therapeutic strategy on ERα degradation by targeting USP15-ERα axis. Nature Publishing Group UK 2021-03-26 /pmc/articles/PMC7997968/ /pubmed/33771975 http://dx.doi.org/10.1038/s41419-021-03607-w Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Xia, Xiaohong Huang, Chuyi Liao, Yuning Liu, Yuan He, Jinchan Shao, Zhenlong Hu, Tumei Yu, Cuifu Jiang, Lili Liu, Jinbao Huang, Hongbiao The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression |
title | The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression |
title_full | The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression |
title_fullStr | The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression |
title_full_unstemmed | The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression |
title_short | The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression |
title_sort | deubiquitinating enzyme usp15 stabilizes erα and promotes breast cancer progression |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997968/ https://www.ncbi.nlm.nih.gov/pubmed/33771975 http://dx.doi.org/10.1038/s41419-021-03607-w |
work_keys_str_mv | AT xiaxiaohong thedeubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT huangchuyi thedeubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT liaoyuning thedeubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT liuyuan thedeubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT hejinchan thedeubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT shaozhenlong thedeubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT hutumei thedeubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT yucuifu thedeubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT jianglili thedeubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT liujinbao thedeubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT huanghongbiao thedeubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT xiaxiaohong deubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT huangchuyi deubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT liaoyuning deubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT liuyuan deubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT hejinchan deubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT shaozhenlong deubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT hutumei deubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT yucuifu deubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT jianglili deubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT liujinbao deubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression AT huanghongbiao deubiquitinatingenzymeusp15stabilizeseraandpromotesbreastcancerprogression |